Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase EARLY_PHASE1 3Phase 1 3Phase 3 1

Status

Recruiting 3Completed 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Genitourinary 1

Conditions

Brain Neoplasms 2Prostatic Neoplasms 1

Interventions

Cyclophosphamide 118Specimen Handling 104pembrolizumab 103Magnetic Resonance Spectroscopy 95fludarabine 93Biopsy 77Injections 53Nivolumab 43Bevacizumab 41Fluorouracil 38venetoclax 37Cisplatin 37Paclitaxel 35Cetuximab 35Carboplatin 35Radiotherapy 31Oxaliplatin 30fludarabine phosphate 29Gemcitabine 29Leucovorin 28Drug Therapy 25Ipilimumab 23Immunotherapy, Adoptive 23Azacitidine 23Radiation 21Irinotecan 21Temozolomide 20130-nm albumin-bound paclitaxel 20tislelizumab 19atezolizumab 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Recruiting × fluciclovine F-18 × Clear all
NCT06048094 2026-05-20

FACILITATE

Baptist Health South Florida

Phase 1 Recruiting
46 enrolled
CNS

Brain Neoplasms

NCT04689048 2026-04-22

Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery

Baptist Health South Florida

Phase 1 Recruiting
20 enrolled
CNS

Brain Neoplasms

NCT06062745 2025-11-05

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

Brigham and Women's Hospital

Phase 1 Recruiting
30 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡